Evidence map›Paper›PMID 25143726›Full record

SynthesisInternational journal of nanomedicine2014

Therapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic review.

Larissa T Alvarim, Leopoldo P Nucci, Javier B Mamani, Luciana C Marti, Marina F Aguiar, Helio R Silva, Gisele S Silva, Mariana P Nucci-da-Silva, Elaine A DelBel, Lionel F Gamarra

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cell tracking technologies for acute ischemic brain injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Larissa T AlvarimHospital Israelita Albert Einstein, São Paulo, Brazil ; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.
Leopoldo P NucciUniversidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.
Javier B MamaniHospital Israelita Albert Einstein, São Paulo, Brazil.
Luciana C MartiHospital Israelita Albert Einstein, São Paulo, Brazil.
Marina F AguiarHospital Israelita Albert Einstein, São Paulo, Brazil ; Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.
Helio R SilvaHospital Israelita Albert Einstein, São Paulo, Brazil ; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.
Gisele S SilvaHospital Israelita Albert Einstein, São Paulo, Brazil.
Mariana P Nucci-da-SilvaDepartamento de Radiologia, Hospital das Clínicas, Universidade de São Paulo, Brazil.
Elaine A DelBelUniversidade de São Paulo-Faculdade de Odontologia de Ribeirão Preto, São Paulo, Brazil ; NAPNA-Núcleo de Apoio a Pesquisa em Neurociências Aplicadas, São Paulo, Brazil.
Lionel F GamarraHospital Israelita Albert Einstein, São Paulo, Brazil ; Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil ; Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in clinical trials assessing the efficacy of cell therapy for structural and functional regeneration of the nervous system in diseases related to the aging brain is well known. However, the results are inconclusive as to the best cell type to be used or the best methodology for the homing of these stem cells. This systematic review analyzed published data on SPION (superparamagnetic iron oxide nanoparticle)-labeled stem cells as a therapy for brain diseases, such as ischemic stroke, Parkinson's disease, amyotrophic lateral sclerosis, and dementia. This review highlights the therapeutic role of stem cells in reversing the aging process and the pathophysiology of brain aging, as well as emphasizing nanotechnology as an important tool to monitor stem cell migration in affected regions of the brain.

Indexed as

BrainStem Cell TransplantationAnimalsBrain DiseasesCell LineCellular SenescenceHumansMagnetite NanoparticlesMiceRatsMagnetite Nanoparticlesbrain agingdementiairon oxideParkinson’s diseasesclerosis diseasestem cellstroke

Identifiers

PMID25143726
PMCPMC4137998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.